@article{9a1e40c619bc4ba391f9279f0e21aa9f,
title = "Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: Summary statement of a First National Institutes of Health/Office of Rare Diseases conference",
author = "Meral Gunay-Aygun and Avner, \{Ellis D.\} and Bacallao, \{Robert L.\} and Choyke, \{Peter L.\} and Flynn, \{Joseph T.\} and Germino, \{Gregory G.\} and Lisa Guay-Woodford and Peter Harris and Theo Heller and Julie Ingelfinger and Frederick Kaskel and Robert Kleta and LaRusso, \{Nicholas F.\} and Parvathi Mohan and Pazour, \{Gregory J.\} and Shneider, \{Benjamin L.\} and Torres, \{Vicente E.\} and Patricia Wilson and Colleen Zak and Jing Zhou and Gahl, \{William A.\}",
note = "Funding Information: Supported in part by the Intramural Research Program of the NIH, specifically, that of the National Human Genome Research Institute, and by the Office of Rare Diseases, Office of the Director, NIH, and ARPKD/CHF Alliance. Funding Information: Researchers and clinicians with expertise in autosomal recessive polycystic kidney disease and congenital hepatic fibrosis (ARPKD/CHF) and related fields met on May 5-6, 2005, on the National Institutes of Health (NIH) campus for a 1.5-day symposium sponsored by the NIH Office of Rare Diseases, the National Human Genome Research Institute (NHGRI), and in part by the ARPKD/CHF Alliance. The meeting addressed the present status and the future of ARPKD/CHF research. ",
year = "2006",
month = aug,
doi = "10.1016/j.jpeds.2006.03.014",
language = "English",
volume = "149",
pages = "159--164",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Elsevier Inc.",
number = "2",
}